Track topics on Twitter Track topics that are important to you
15801 Crabbs Branch Way
United States of America
Biotechnology major BioCon is likely to take its group entity Biocon Biologics public and is expected to raise about $500M.
Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in the global market to make up for time lost due to manufacturing issues. It has...
Biocon has launched its biosimilar Avastin in India, intensifying competition on the market. In addition to its ‘affordable’ price, Biocon’s...
Two Indian firms – Biocon and Dr Reddy’s – have received crucial establishment inspection reports (EIRs) from the US FDA...
Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the nod from the FDA, after receiving a CRL related manufactur...
A US FDA pre-approval inspection of Bioconâs insulin manufacturing facility in Malaysia has resulted in a Form 483 with six observations.
In August, Biocon had withdrawn two applications for approval of proposed biosimilars after the EMA said it would need to reinspect a drug facility.
The FDA has approved Mylan and Biocon’s biosimilar of Roche’s Herceptin (trastuzumab) breast cancer drug after a delay because of manufacturing issues. The FDA had previously rejected the biosimi...
Established in 1978, Biocon Limited is India's largest biotechnology Company by revenue. The Group, promoted by Ms. Kiran Mazumdar-Shaw, is a fully-integrated, innovation-driven h...
Born out of Germany´s "BioRegio" competition in 1996 BioCon Valley represents an interdisciplinary network in the field of modern life sciences and health care.Universities, research and health care ...
Biocon is India's leading biotechnology enterprise. Over the past 25 years, we have evolved from an enzyme manufacturing company to a fully integrated biopharmaceutical enterprise, focused on healthca...
Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and co...
We have published hundreds of BIOCON, INC. news stories on BioPortfolio along with dozens of BIOCON, INC. Clinical Trials and PubMed Articles about BIOCON, INC. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BIOCON, INC. Companies in our database. You can also find out about relevant BIOCON, INC. Drugs and Medications on this site too.